Stephen Yoo, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 36,928 shares at $63.67 ($2.3M) on 2018-10-29, disclosed to the SEC on 2018-10-31.
Open-market sale of $2.3M RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.83 | 3,042 | $182K | 7.9% |
| 2 | $59.83 | 3,042 | $182K | 7.9% |
| 3 | $60.66 | 1,700 | $103K | 4.5% |
| 4 | $61.82 | 2,100 | $130K | 5.6% |
| 5 | $62.93 | 8,026 | $505K | 21.9% |
| 6 | $62.93 | 8,026 |
| $505K |
| 21.9% |
| 7 | $63.67 | 5,446 | $347K | 15.0% |
| 8 | $63.67 | 5,446 | $347K | 15.0% |
| 9 | $64.42 | 100 | $6K | 0.3% |
| Total | $62.47 avg | 36,928 | $2.3M | 100% |
| Filing → |
| RGNX | SELL | 2018-11-07 | $2.5M | — | Filing → |
| RGNX | SELL | 2018-10-17 | $1.9M | — | Filing → |
| RGNX | SELL | 2017-09-12 | $684K | — | Filing → |